ONE STAGE CHRONOMETRIC FVIII ASSAY OR TWO STAGE CHROMOGENIC FVIII ASSAY TO DIAGNOSE HAEMOPHILIA A?

被引：0
|
作者：
Marchand, K. [1 ]
Benoit, R. [1 ]
Martin, M. [2 ]
Fretigny, M. [3 ]
Toussaint-Hacquard, M. [1 ]
Frotscher, B. [2 ]
机构：
[1] Univ Hosp Nancy, Lab Haematol, Vandoeuvre Les Nancy, France
[2] Univ Hosp Nancy, Haemophilia Treatment Ctr, Vandoeuvre Les Nancy, France
[3] Univ Hosp Lyon, Lab Genet, Lyon, France
来源：
HAEMOPHILIA | 2022年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO012
引用
收藏
页码：30 / 30
页数：1
相关论文
共 50 条
  • [31] A COLLABORATIVE COMPARISON OF A CHROMOGENIC-FVIII-C METHOD WITH ONE-STAGE AND 2-STAGE CLOTTING METHODS
    ROSEN, S
    OSWALDSSON, U
    BLOMBACK, M
    LARRIEU, M
    NILSSON, IM
    VINAZZER, H
    THROMBOSIS AND HAEMOSTASIS, 1983, 50 (01) : 112 - 112
  • [32] Accuracy of FVIII:C assay by one-stage method can be improved using hemophilic plasma as diluent
    Cinotti, S
    Paladino, E
    Morfini, M
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (04) : 828 - 833
  • [33] DISCREPANCY BETWEEN 1-STAGE AND 2-STAGE ASSAY FOR VIII-C - INADEQUACY OF THE 2 STAGE ASSAY TO MEASURE FVIII IN HEPARINIZED BLOOD
    ROCK, GA
    PERKINS, H
    PALMER, DS
    THROMBOSIS AND HAEMOSTASIS, 1983, 50 (01) : 244 - 244
  • [34] Effect of measuring FVIII chromogenically in the Bethesda assay for FVIII inhibitors
    Kershaw, G.
    Jayakodi, D.
    Dunkley, S.
    HAEMOPHILIA, 2010, 16 : 86 - 86
  • [35] One-stage assay analysis demonstrates that gene therapy-derived factor VIII (FVIII) from dirloctocogene samoparvovec reduced clot times compared with endogenous FVIII at comparable FVIII levels
    Rizzo, C.
    Rojas, I. Y.
    Blanchard, E. L.
    Lupo, D.
    Chang, T.
    Coleman, J.
    Howard, V.
    Peed, L.
    Straub, R.
    Hanby, H.
    Alexander, J. M.
    Riling, C. R.
    HAEMOPHILIA, 2024, 30 : 63 - 63
  • [36] ONE STAGE AND CHROMOGENIC FVIII ASSAY RESULTS AT TROUGH LEVELS: A UK NATIONAL EXTERNAL QUALITY ASSESSMENT SCHEME FOR BLOOD COAGULATION (UK NEQAS BC) EXERCISE
    Lowe, A.
    Jennings, I.
    Kitchen, S.
    Kitchen, D.
    Brown, L.
    Munroe-Peart, S.
    Woods, T.
    Walker, I.
    HAEMOPHILIA, 2020, 26 : 27 - 27
  • [37] Usefulness of Chromogenic Assay in Measuring FVIII Activity of Hemophiliac Patients Receiving Emicizumab
    Yamaguchi, Tomoko
    Inaba, Hiroshi
    Miyashita, Ryui
    Kamikubo, Yoshiko
    Chikasawa, Yushi
    Yotsumoto, Mihoko
    Shinozawa, Keiko
    Hagiwara, Takeshi
    Amano, Kagehiro
    Kinai, Ei
    PEDIATRIC BLOOD & CANCER, 2020, 67
  • [38] Progress Curve Analysis of the one stage chromogenic assay for ecarin
    Johnson, Lambro A.
    de Jersey, John
    Masci, Paul P.
    Zhao, Kong-Nan
    Bennett, Nigel C.
    Dimeski, Goce
    Grant, Michael
    Lavin, Martin F.
    ANALYTICAL BIOCHEMISTRY, 2020, 608
  • [39] Assay Interference By Emicizumab in Aptt and Chromogenic Based FVIII:C and Inhibitor Assays
    Poirier, Brian F.
    Robinson, Mary
    Tiefenbacher, Stefan
    McEwan, Erin
    Cogswell, Caroline
    Gode, Roxy
    Burger, Emily
    Allison, Tyler
    Littlefield, Jennifer
    Pikas, Amanda
    Schmoker, Andrea
    BLOOD, 2020, 136
  • [40] Evaluation of Chromogenic Factor VIII Assay Compared with One-Stage Clotting Assay
    Akkaya, Emre
    Hatiboglu, Songul
    Koc, Basak
    Genc, Sema
    Unuvar, Aysegul
    Karaman, Serap
    Omer, Beyhan
    Karakas, Zeynep
    Zulfikar, Bulent
    CLINICAL LABORATORY, 2020, 66 (10) : 1937 - 1943
12345